Background: Trigeminal neuralgia (TN) refers to sharp, lancinating pain in the areas supplied by trigeminal nerve. Both pharmacological and surgical lines of treatments are available for the treatment of TN. Percutaneous balloon compression (PBC) is one such surgical technique that is usually advocated for the treatment of TN occurring in elderly patients. Hence, we aim to evaluate the follow-up results of the TN patients treated by the PBC technique.
INTRODUCTION
Trigeminal neuralgia (TN) refers to the intense neuropathic pain that arises in one or more than one division of 5th cranial nerve: the trigeminal nerve. Based on the type of etiologic agent involved, TN is of four main types, namely atypical, idiopathic, secondary, and postherpetic. 1 On the basis of the pain's clinical features or characteristics, TN is further classified into two types: Classical TN (CTN) and mixed TN (MTN). 2 It has been referred to as kephalalgias by Galen and Hippocrates. The name Tic Douloureux was given to TN in 1756 by Andre. According to Jhon Hunter, TN is a pathologic state of nervous system in which pain appears to be arising from teeth, gums, and tongue where in actual state, no pathology, disease, or lesion is present. 3, 4 For treatment of the cases of TN, both the medicinal therapy and surgical therapy are available. For the medicinal part, Carbamazepine and Gabapentine forms the first line of drugs. In case the patient does not respond to the medicinal therapy or the patient is resistant to the pharmacological means, surgical treatment is the only main line of treatment left. Various surgical modalities for
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the treatment of TN include neurectomy, blockage of the nerve by glycerol, rhizotomy by radiofrequency, gamma knife surgery, and trigeminal ganglion compression. 5 Therefore, we evaluated the long-term prognosis of patients in which percutaneous balloon compression (PBC) technique was used for the treatment of TN.
MATERIALS AND METHODS
All the patients who had undergone PBC for the treatment of TN were included for the study. The patient data were collected from the year 2005 to 2010 for all the above-mentioned treated cases. Inclusion criteria included patients who reported in hospitals with the chief complaint of neuralgic pain (paroxysmal pain of sharp, electric shock-like nature) and who did not respond well to pharmacological line of treatment. Patients giving history of other systemic diseases or lesions (multiple sclerosis, any kind of malignancies, or tumors) were excluded from the study. Only those patients were counted in the study for which follow-up data of a minimum of 4 years were available. After applying the exclusion criteria, a total of 400 patients were left for this study. Out of 400, 220 were females and 180 were males. All the surgical procedures were performed by a registered oral surgeon. Assessment and evaluation of individual symptoms of TN, clinical findings, and postoperative complications was done and a separate record was maintained for all of the above-mentioned data. Follow-up record was maintained in the form of questioner, clinical examination, and complete checkup to look for any complication. Regular follow-up was done after every 2 months. All the follow-up data were recorded and assessed by a registered oral surgeon only. Patients in whom clinical signs and symptoms of neuralgic pain subsided were considered as successful. Facial pain arising due to any other reason in these patients postoperatively, who did not fulfill the criterion of neuralgic pain, was not considered as treatment failure. Results obtained were statistically analyzed using Statistical Package for the Social Sciences (SPSS) software. One-way analysis of variance (ANOVA) was used to assess the level of significance (p < 0.05 is significant).
RESULTS
The results of the present study are summarized in Tables 1 to 5 . We included a total of 400 patients for the study, of whom 353 patients showed an improvement clinically after PBC therapy. Out of 400, 180 were males and 220 were females ( Table 1 , Graph 1) (p < 0.05). A total of 232 patients were above 50 years of age, while 168 were below 50 years (Table 2, Graph 2). We also divided the patients on basis of duration of TN. One hundred fifty-one patients had a TN history of more than 10 years (Table 3 , Graph 3). While assessing the data regarding the most commonly side of the face affected, we observed that in more than 65% of cases, right side of the face was affected by the lesion (Table 4 , Graph 4). Facial numbness, 
DISCUSSION
One of the most common cause of facial neuralgia is the TN comprising more than 25 cases per one lakh population and is often regarded as one of the most painful condition affecting the patients. 6, 7 Different researchers advocate different treatment modalities for treating TN, but all the available treatment options have their own limitations. Hence, we assessed the follow-up results of TN patients treated with PBC. More than 50% of the patients in our study were females (Table 1) . Manzoni and Torelli (2005) also mentioned that male-to-female ration in TN cases is approximately 2:3. 8 In our study; we observed that TN was more common in patients above 50 years of age (Table 2 ). Pollock and Stien 9 and Koopman et al 10 also mentioned in their work that TN is significantly more common and prevent in person above 50 years of age and the frequency of its occurrence increases with age. We also evaluated in postoperative complications arising in TN patients treated by PBC. In our study (Table 5) , facial numbness was the post common complication seen in TN-treated patients followed by masseter muscle weakness, paresthesia, diplopia, and corneal anesthesia. Surgical treatment involving PBC aims to alter the triggering lancinating pain of TN by injuring the myelinated fibers. As unmyelinated fibers mediate the corneal reflex, the reflex is also lost when these fibers are injured. 11 Percutaneous balloon compression techniques aiming at trigeminal ganglion are known to cause a number of consequences, such as paresthesia, masseter muscle weakness, hypoesthesia, etc. 12 Our results were in correlation with the results of Du et al 13 who noticed facial numbness as the most prevalent postsurgical complication in their series of TN patients. In a series of TN cases studied by Günther et al, 14 they observed that with approximately eight and half year follow-up, complications did occur postoperatively in their series. These complications mainly included hypesthesia, hypacusis, partial facial nerve palsy, 17 Campos and Linhares postoperative follow-up of 39 patients if TN treated by PBC. They observed that postoperative hypoesthesia can be regarded as a single prognostic factor that can positively alter the results. They concluded that PBC is a safe procedure with a very low range of side effects, low morbidity rate, and offers additional advantages over other surgical methods. 12 Park et al 19 retrospectively surveyed 50 TN patients who were treated by PBC, and from the results, they also favored PBC technique for the treatment of TN over other surgical modalities.
CONCLUSION
Trigeminal neuralgia is one of the most common causes of facial neuralgia and has a significant impact on the quality of life of the patients. Diagnosis of TN is very important, as some other lesions and dental pathologies can also mimic TN. Various surgical modalities are available for the treatment of TN out of which PBC offers numerous advantages. From the results, we can conclude that it is a better option for surgical treating TN, as it is minimally invasive, comparatively cost-effective, and offers comparatively minimal complications during the postoperative life of the treated patients.
